ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
$6.97 -0.19 (-2.6536%)
Analysed ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) News Sources
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
23-03-2026
fool.com
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf
23-03-2026
marketbeat.com
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
25-03-2026
fool.com
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates
30-04-2026
yahoo.com
Arcturus Therapeutics Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
07-05-2026
yahoo.com
Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
05-06-2026
marketbeat.com
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
02-07-2026
yahoo.com
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?
03-07-2026
yahoo.com
What is the current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is $6.97.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is $-0.19.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is -2.6536%.
What is the most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is .
SEC-8K** Filing Available For ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.